207 related articles for article (PubMed ID: 25031014)
1. Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing.
Paniz-Mondolfi A; Singh R; Jour G; Mahmoodi M; Diwan AH; Barkoh BA; Cason R; Huttenbach Y; Benaim G; Galbincea J; Luthra R
Virchows Arch; 2014 Sep; 465(3):339-50. PubMed ID: 25031014
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous carcinosarcoma: insights into its clonal origin and mutational pattern expression analysis through next-generation sequencing.
Paniz Mondolfi AE; Jour G; Johnson M; Reidy J; Cason RC; Barkoh BA; Benaim G; Singh R; Luthra R
Hum Pathol; 2013 Dec; 44(12):2853-60. PubMed ID: 24071013
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses.
Harms PW; Fullen DR; Patel RM; Chang D; Shalin SC; Ma L; Wood B; Beer TW; Siddiqui J; Carskadon S; Wang M; Palanisamy N; Fisher GJ; Andea A
Hum Pathol; 2015 May; 46(5):690-7. PubMed ID: 25704628
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition.
Kwon D; Ronen S; Giubellino A; Keiser E; Aung PP; Nagarajan P; Tetzlaff MT; Ivan D; Curry JL; Prieto VG; Torres-Cabala CA
J Cutan Pathol; 2021 Apr; 48(4):526-534. PubMed ID: 32564423
[TBL] [Abstract][Full Text] [Related]
5. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder.
Armstrong AB; Wang M; Eble JN; MacLennan GT; Montironi R; Tan PH; Lopez-Beltran A; Zhang S; Baldridge LA; Spartz H; Cheng L
Mod Pathol; 2009 Jan; 22(1):113-8. PubMed ID: 18997737
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis.
Kiuru M; McDermott G; Coit DC; Berger MF; Busam KJ
Am J Surg Pathol; 2014 Jan; 38(1):138-42. PubMed ID: 24335643
[TBL] [Abstract][Full Text] [Related]
9. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis.
Holst VA; Finkelstein S; Colby TV; Myers JL; Yousem SA
Am J Surg Pathol; 1997 Jul; 21(7):801-11. PubMed ID: 9236836
[TBL] [Abstract][Full Text] [Related]
10. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
Moukarzel LA; Ferrando L; Da Cruz Paula A; Brown DN; Geyer FC; Pareja F; Piscuoglio S; Papanastasiou AD; Fusco N; Marchiò C; Abu-Rustum NR; Murali R; Brogi E; Wen HY; Norton L; Soslow RA; Vincent-Salomon A; Reis-Filho JS; Weigelt B
Mol Oncol; 2021 Apr; 15(4):1024-1039. PubMed ID: 33021035
[TBL] [Abstract][Full Text] [Related]
11. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
Liu Y; Weber Z; San Lucas FA; Deshpande A; Jakubek YA; Sulaiman R; Fagerness M; Flier N; Sulaiman J; Davis CM; Fowler J; Starks D; Rojas-Espaillat L; Lazar AJ; Davies GE; Ehli EA; Scheet P
Gynecol Oncol; 2018 Nov; 151(2):243-249. PubMed ID: 30194005
[TBL] [Abstract][Full Text] [Related]
12. Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects.
Torenbeek R; Hermsen MA; Meijer GA; Baak JP; Meijer CJ
J Pathol; 1999 Nov; 189(3):338-43. PubMed ID: 10547594
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma with osteosarcomatous component.
Tse JY; Pawlak AC; Boussahmain C; Routhier CA; Dias-Santagata D; Kalomiris D; Hoang MP
Am J Dermatopathol; 2013 Apr; 35(2):261-5. PubMed ID: 23221485
[TBL] [Abstract][Full Text] [Related]
14. Trichoblastic carcinosarcoma in a 34-year-old woman with histopathologic and molecular analysis, including re-demonstration of a CDKN2A p.(R58*) mutation.
Kim C; Brown A; Osipov V
J Cutan Pathol; 2021 Feb; 48(2):334-339. PubMed ID: 33089535
[TBL] [Abstract][Full Text] [Related]
15. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
Amatya VJ; Takeshima Y; Kaneko M; Inai K
Pathol Int; 2004 Oct; 54(10):803-9. PubMed ID: 15482572
[TBL] [Abstract][Full Text] [Related]
16. Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.
Trento M; Munari G; Carraro V; Lanza C; Salmaso R; Pizzi S; Santoro L; Chiarelli S; Dal Santo L; Nardelli GB; Saccardi C; Nicoletto O; Baldoni A; Rugge M; Fassan M
Int J Gynecol Pathol; 2020 Jul; 39(4):305-312. PubMed ID: 31688243
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Carcinosarcoma and Concurrent Serous Tubal Intraepithelial Carcinoma With Next-Generation Sequencing Suggesting an Origin From the Fallopian Tube.
See SHC; Behdad A; Maniar KP; Blanco LZ
Int J Surg Pathol; 2019 Aug; 27(5):574-579. PubMed ID: 30913944
[No Abstract] [Full Text] [Related]
18. Case report and literature review: primary cutaneous carcinosarcoma.
Ram R; Saadat P; Peng D; Vadmal M
Ann Clin Lab Sci; 2005; 35(2):189-94. PubMed ID: 15943184
[TBL] [Abstract][Full Text] [Related]
19. Primary Cutaneous Carcinosarcoma of the Basal Cell Subtype Should Be Treated as a High-Risk Basal Cell Carcinoma.
Bourgeault E; Alain J; Gagné E
J Cutan Med Surg; 2015; 19(4):407-11. PubMed ID: 25775619
[TBL] [Abstract][Full Text] [Related]
20. Carcinosarcomas: tumors in transition?
Somarelli JA; Boss MK; Epstein JI; Armstrong AJ; Garcia-Blanco MA
Histol Histopathol; 2015 Jun; 30(6):673-87. PubMed ID: 25587806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
